Grapiprant and Pembrolizumab in Patients With Advanced or Progressive MSS Colorectal Cancer
Clinical trial NCT03658772 · COMPLETED
Trial details
- NCT number
- NCT03658772
- Sponsor
- Arrys Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-20
- Primary completion
- 2023-03-07
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.